Image

Global Blood Culture Test Market - Industry Trends and Forecast to 2030

Healthcare

Image

Global Blood Culture Test Market - Industry Trends and Forecast to 2030

  • Healthcare
  • Upcoming Report
  • Oct 2023
  • Global
  • 270 Pages
  • No of Tables: 80
  • No of Figures: 130

Global Blood Culture Test Market - Industry Trends and Forecast to 2030

Market Size in USD Billion

CAGR :  % Diagram

Diagram Forecast Period 2022–2030
Diagram Market Size (Base Year) USD 4900.00 Million
Diagram Market Size (Forecast Year) USD 8400.00 Million
Diagram CAGR %

Global Blood Culture Test Market, By Method (Conventional/Manual Methods and Automated Methods), Product (Consumables, Instruments and Software and Services), Technology (Culture-Based Technology, Molecular Technologies and Proteomics Technology), Application (Bacteraemia, Fungaemia and Mycobacterial Detection), End-User (Hospital Laboratories, Reference Laboratories, Academic Research Laboratories and Other Laboratories) - Industry Trends and Forecast to 2030.

Blood Culture Tests Market

Blood Culture Test Market Analysis and Size

Rising prevalence of sepsis and other blood related infections is a root cause for the rise in blood culture test market value. Growing approval rate of new products, such as instruments and consumables for Bloodstream Infections (BSI) diagnosis will further create lucrative and remunerative opportunities for the Blood culture test market.

Data Bridge Market Research analyses that the blood culture test market which was USD 4,900.00 million in 2022, is expected to reach USD 8,400.00 million by 2030, and is expected to undergo a CAGR of 6.0% during the forecast period of 2023 to 2030. “Automated Methods” dominates the method segment of the blood culture test market owing to the increasing prevalence of bloodstream infections. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Blood Culture Test Market Scope and Segmentation

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customizable to 2015-2020)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Method (Conventional/Manual Methods and Automated Methods), Product (Consumables, Instruments and Software and Services), Technology (Culture-Based Technology, Molecular Technologies and Proteomics Technology), Application (Bacteraemia, Fungaemia and Mycobacterial Detection), End User (Hospital Laboratories, Reference Laboratories, Academic Research Laboratories and Other Laboratories)

Countries Covered

U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, U.A.E., Egypt, Israel, Rest of Middle East and Africa

Market Players Covered

BD (U.S.), Abbott Laboratories (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Novartis AG (Switzerland), Eli Lilly and Company (U.S.) Terumo Corporation (Japan), Bruker Corporation ( U.S.), bioMérieux SA (France), Bayer AG (Germany), Merck & Co., Inc. (U.S.), Thermo Fisher Scientific Inc., (U.S.), Siemens Healthcare GmbH: (Germany), Danaher Corporation (U.S.), ZenTech S.A. (Belgium), ZeptoMetrix Corporation (U.S.), BioFire Diagnostics (a subsidiary of bioMérieux) (U.S.), CytoTest Inc. (U.S.), Mikroscan Technologies, Inc. (U.S), Leica Biosystems Nussloch GmbH (a subsidiary of Danaher) (Germany), Devyser (Sweden)

Market Opportunities

  • Adoption of molecular diagnostic techniques
  • Integration of data management and connectivity solutions

Market Definition

Blood culture test are undergone to detect the presence of any microorganisms such as bacteria or fungi in the blood. Presence of bacteria, fungi or yeast in the blood will result in blood infection and give birth to many diseases. Blood culture test are used to determine the presence of infection, causative agents and to further help to healthcare provider in deciding the course of treatment.

Global Blood Culture Test Market Dynamics

Drivers

  • Increasing Prevalence of Bloodstream Infections

The rising incidence of bloodstream infections, including sepsis, is a major driver for the blood culture market. Blood culture test are vital for accurate diagnosis, appropriate treatment, and improved patient outcomes.

  • Growing Awareness and Initiatives for Infection Control

There is a heightened focus on infection control measures in healthcare settings, leading to increased adoption of Blood culture test. Efforts to prevent healthcare-associated infections and implement surveillance programs drive the demand for blood culture solutions.

Opportunity

  • Adoption of Molecular Diagnostic Techniques

The adoption of molecular diagnostic techniques, such as polymerase chain reaction (PCR) and nucleic acid amplification, in blood culture testing presents opportunities for faster and more accurate pathogen detection.

Restraint/Challenge

  • Lack of Skilled Professionals

Adequate training and expertise are required for performing and interpreting Blood culture test accurately. The shortage of skilled laboratory professionals can be a restraint, particularly in certain regions, affecting the widespread implementation of blood culture testing.

This blood culture test market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the blood culture test market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Development

  • In May 2021, F. Hoffmann-La Roche Ltd acquired GenMark Diagnostics to expand its molecular diagnostics portfolio with GenMark’s expertise in syndromic testing. GenMark's ePlex systems enhance Roche's work in managing infectious diseases and antibiotic resistance. The ePlex platform is designed to detect multiple pathogens from a single rapid test and a patient sample, allowing clinicians to determine the cause of infection and prescribe treatment within hours. Panther Healthcare launched the Smart Powered Stapler platform, which provides intelligent and automated control of tissue fixation, transection and resection across gastrointestinal (including bariatric), thoracic, colorectal, oncology, gynecology and other open and laparoscopic surgical procedures. The device was released in Europe, the Middle East, Africa, Asia and Latin America

Global Blood Culture Test Market Scope

The blood culture test market is segmented on the basis of method, product, technology, application and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Method

  • Conventional/Manual Methods
  • Automated Methods

Product

  • Consumables
  • Instruments
  • Software and Services

Technology

  • Culture-Based Technology
  • Molecular Technologies
  • Proteomics Technology

Application

  • Bacteraemia
  • Fungaemia
  • Mycobacterial Detection

End-User

  • Hospital Laboratories
  • Reference Laboratories
  • Academic Research Laboratories
  • Other

Global Blood Culture Test Market Regional Analysis/Insights

The blood culture test market is analysed and market size insights and trends are provided by country, method, product, technology, application and end user as referenced above.

The countries covered in the blood culture test market report are U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, U.A.E., Egypt, Israel, Rest of Middle East and Africa

North America dominates the market and will continue to during the forecast period. This is because of the prevalence of a favourable reimbursement scenario and occurrence of major key players.

Asia-Pacific on the other hand is set to project the highest CAGR for the forecast period. This is because of the rising expenditure of healthcare infrastructure, rising investments for research and development activities and increasing prevalence of various blood related infections.

The country s section of the blood culture test market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Competitive Landscape and Blood Culture Test Market Share Analysis

The blood culture test market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the company’s focus related to blood culture test market.

Some of the major players operating in the blood culture test market are:

  • BD (U.S.)
  • Abbott Laboratories (U.S.)
  • F. Hoffmann-La Roche Ltd (Switzerland)
  • Novartis AG (Switzerland)
  • Eli Lilly and Company (U.S.)
  • Terumo Corporation (Japan)
  • Bruker Corporation (U.S.)
  • bioMérieux SA (France)
  • Bayer AG (Germany)
  • Merck & Co., Inc. (U.S.)
  • Thermo Fisher Scientific Inc. (U.S.)
  • Siemens Healthcare GmbH (Germany)
  • Danaher Corporation (U.S.)
  • ZenTech S.A. (Belgium)
  • ZeptoMetrix Corporation (U.S.)
  • BioFire Diagnostics (a subsidiary of bioMérieux) (U.S.)
  • CytoTest Inc. (U.S.)
  • Mikroscan Technologies, Inc. (U.S.)
  • Leica Biosystems Nussloch GmbH (a subsidiary of Danaher) (Germany)
  • Devyser (Sweden)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

The blood culture test market size will be worth USD 8,400.00 million by 2030.
The growth rate of the blood culture test market is 6.0% in the forecast period by 2030.
The increasing prevalence of bloodstream infections, growing awareness, and initiatives for infection control are the growth drivers of the blood culture test market.
Method, product, technology, application, and end-user are the factors on which the blood culture test market research is based.
Major companies in the blood culture test market are BD (U.S.), Abbott Laboratories (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Novartis AG (Switzerland), Eli Lilly and Company (U.S.) Terumo Corporation (Japan), Bruker Corporation ( U.S.), bioMérieux SA (France), Bayer AG (Germany), Merck & Co., Inc. (U.S.), Thermo Fisher Scientific Inc., (U.S.), Siemens Healthcare GmbH: (Germany), Danaher Corporation (U.S.), ZenTech S.A. (Belgium), ZeptoMetrix Corporation (U.S.), BioFire Diagnostics (a subsidiary of bioMérieux) (U.S.), CytoTest Inc. (U.S.), Mikroscan Technologies, Inc. (U.S), Leica Biosystems Nussloch GmbH (a subsidiary of Danaher) (Germany), Devyser (Sweden)
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials